Mistletoe preparations are also sometimes administered as infusions under medical supervision. This application represents a kind of off-label use, i.e. after information and with the consent of the patient on the responsibility of the physician. Mistletoe therapy then has a more intensive effect in certain situations.
Often this is preceded by a phase with mistletoe injections under the skin, which is usually continued in parallel. In intravenous application, the concentration of mistletoe extract is slowly increased from infusion to infusion over several days, sometimes even weeks, depending on the reaction. In the case of an unstable disease situation or a weakened state of strength, such mistletoe infusions, added to the subcutaneous application, may even impressively stabilize the patient’s physical and emotional condition. Normally no fever occurs.
With high doses of mistletoe infusions, often in combination with mistletoe injections under the skin, the person’s body temperature can rise significantly over several hours, even to a high fever. This stimulates the immune system. However, this treatment requires appropriate medical experience, close monitoring and a sufficiently stable state of strength in the patient. After the fever has subsided, the patient often feels energized and strengthened.
During chemotherapy in particular, additional mistletoe infusions have often proven to be helpful. Experience shows that patients often feel much more vital and suffer less from fatigue. With advanced tumour disease, loss of strength and weight loss they often feel significantly stabilised, appetite returns and physical activities such as walking become possible again.
Intravenous application increases the risk of side effects, such as pseudoallergic reactions (especially if the infusion administered is too fast). For this reason, this form of therapy may only be carried out after a previous initial phase with subcutaneous injections and only in the doctor's practice or hospital under the supervision of a doctor experienced in this type of application. If the infusion runs very slowly, such undesired reactions occur less frequently. Therefore, such an infusion usually lasts between two to four hours. During this time the patient should be observed carefully, so during the first 15 minutes.
Last update: May 4th, 2020AB